Walgreens Boots Alliance (WBA)
$51.16
0.68 (1.35%)
WBA Stock Quote Delayed 15 Minutes
Previous Close
$51.16
Market Cap
50.77B
PE Ratio
11.98
EPS
4.27
Volume (Avg. Vol.)
5.13M
Day's Range
50.61 - 51.44
52-Week Range
49.12 - 86.31
Dividend & Yield
1.68 (3.28%)
WBA Stock Predictions, Articles, and Walgreens Boots Alliance News
New Rite Aid CEO Needs More Than Amazon Partnership to Drive RAD Stock Higher
Heyward Donigan isn't the reason RAD stock has tanked of late. But, if she doesn't appreciate where Rite Aid is wasting money, she may be the reason Rite Aid stock continues to lose ground.
200 Walgreens Stores Closing in U.S.
The Walgreens stores closing list continues to grow as it adds 200 locations in the U.S after reviewing results from its earnings report.
Is CVS Stock a Buy With a 3.5% Dividend and 20% Upside?
CVS Health stock has been under pressure for a while now. But with CVS stock trading better, is it suddenly worth a buy?
The Worst Appears to Be Over for CVS Stock
Over the years, CVS stock has incurred some painful losses in the markets. However, bold moves by management make this a compelling contrarian buy.
Dow Jones Today: Maybe We’re Getting Somewhere
Despite the jitters going into Saturday's G20 meeting, the Dow Jones today was aided by a decent earnings report before the bell from WBA.
Nasdaq Today: iQiyi Surges on Award; Intel, Cisco Struggle
Memory stocks like Micron and semiconductor stocks like AMD were on the move in the Nasdaq today. Intel and Cisco weren't so lucky though.
Walgreens Earnings: WBA Stock Surges on Q3 Beat
Walgreens earnings for the company's fiscal third quarter of the year have WBA stock up Thursday on an EPS and revenue beat.
Dow Jones Today: Steady, But Some Patches of Excitement
Broadly speaking, stocks were steady today as President Trump and Chinese President Xi Jinping head toward the highly anticipated G-20 summit in Japan to discuss, among other issues, trade.
Nasdaq Today: Hard to Keep Track of the Losers
Biotech rallied on a $63 billion deal between AbbVie and Allergan. But other than that, it was a tough day for the Nasdaq today.
Dow Jones Today: A Sleepy Start to the Week, But Hold On
Investors could get some long-awaited excitement as soon as this week as several Dow components are slated to step into the earnings confessional. Here is a rundown of some of the Dow names reporting earnings this week.
CVS Stock Has More Going for It Than Just a 3.69% Dividend Yield
A judge is challenging the CVS Health-Aetna deal and the drug store sector is out of favor. So when will the discount on CVS stock end?
4 Pot Stocks to Own for Full-Blown Federal Marijuana Reform
A few months ago, I was thinking that medical marijuana would become legal in the United States by 2023, with recreational use to follow a few years later. I now expect it to be much sooner than that. And everyone who owns cannabis stocks stands to benefit.
6 Signs That Marijuana Legalization is Closer Than You Think
Based on the facts, news, and trends – not a gut feeling for or against marijuana – I expect legalization soon. And I've got six reasons why.
It’s a Little Dicey, but CVS Stock Actually Might Have Turned the Corner
CVS stock has been bleeding for four years. Now, the light at the end of the tunnel is here for CVS Health.
The New Cigarette Policy Shows Why Walgreens Stock Is Broken
Walgreens is raising the buying age for tobacco to 21. The fact that the company has to do so highlights big problems with Walgreens stock.
There’s a Buy the Dip Opportunity in Walgreens Stock but It Isn’t Now
Walgreens stock tanked after the company reported weak second-quarter results and issued a light outlook, but there's opportunity here.
If You Own Realty Income Stock, It’s Time to Take Your Profits
Realty Income is arguably the best real estate investment trust to buy and hold, but that doesn't mean O stock is a great addition right now.
Walgreens Doctor Offices to Open in Test Markets
Walgreens doctor offices (WBA) are coming in test markets, as you'll be able to see a primary care physician in the same place as your meds.
10 Dow Jones Stocks Holding the Blue Chip Index Back
Pfizer, Walgreens and Merck are just three of the Dow Jones stocks that have kept the index from doing as well as other market indices have this year.
Navellier Ratings
Powered by Portfolio GraderTotal Grade
D
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!
